93 related articles for article (PubMed ID: 12886520)
21. Androgen receptor up-regulates insulin-like growth factor binding protein-5 (IGFBP-5) expression in a human prostate cancer xenograft.
Gregory CW; Kim D; Ye P; D'Ercole AJ; Pretlow TG; Mohler JL; French FS
Endocrinology; 1999 May; 140(5):2372-81. PubMed ID: 10218991
[TBL] [Abstract][Full Text] [Related]
22. Divergent effects of castration on prostate cancer in TRAMP mice: possible implications for therapy.
Tang Y; Wang L; Goloubeva O; Khan MA; Zhang B; Hussain A
Clin Cancer Res; 2008 May; 14(10):2936-43. PubMed ID: 18483360
[TBL] [Abstract][Full Text] [Related]
23. Enhanced androgen receptor signaling correlates with the androgen-refractory growth in a newly established MDA PCa 2b-hr human prostate cancer cell subline.
Hara T; Nakamura K; Araki H; Kusaka M; Yamaoka M
Cancer Res; 2003 Sep; 63(17):5622-8. PubMed ID: 14500404
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of interleukin-6 with CNTO328, an anti-interleukin-6 monoclonal antibody, inhibits conversion of androgen-dependent prostate cancer to an androgen-independent phenotype in orchiectomized mice.
Wallner L; Dai J; Escara-Wilke J; Zhang J; Yao Z; Lu Y; Trikha M; Nemeth JA; Zaki MH; Keller ET
Cancer Res; 2006 Mar; 66(6):3087-95. PubMed ID: 16540658
[TBL] [Abstract][Full Text] [Related]
25. Timing is everything: preclinical evidence supporting simultaneous rather than sequential chemohormonal therapy for prostate cancer.
Eigl BJ; Eggener SE; Baybik J; Ettinger S; Chi KN; Nelson C; Wang Z; Gleave ME
Clin Cancer Res; 2005 Jul; 11(13):4905-11. PubMed ID: 16000589
[TBL] [Abstract][Full Text] [Related]
26. Cell proliferation and apoptosis in prostate tumors and adjacent non-malignant prostate tissue in patients at different time-points after castration treatment.
Ohlson N; Wikström P; Stattin P; Bergh A
Prostate; 2005 Mar; 62(4):307-15. PubMed ID: 15389788
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of human prostate cancer xenograft growth by 125I labeled triple-helix forming oligonucleotide directed against androgen receptor.
Zhang Y; Ma Y; Lu HP; Gao JH; Liang CS; Liu CZ; Zou JT; Wang HQ
Chin Med J (Engl); 2008 Nov; 121(22):2284-9. PubMed ID: 19080333
[TBL] [Abstract][Full Text] [Related]
28. In vivo knockdown of the androgen receptor results in growth inhibition and regression of well-established, castration-resistant prostate tumors.
Snoek R; Cheng H; Margiotti K; Wafa LA; Wong CA; Wong EC; Fazli L; Nelson CC; Gleave ME; Rennie PS
Clin Cancer Res; 2009 Jan; 15(1):39-47. PubMed ID: 19118031
[TBL] [Abstract][Full Text] [Related]
29. Allyl isothiocyanate, a constituent of cruciferous vegetables, inhibits growth of PC-3 human prostate cancer xenografts in vivo.
Srivastava SK; Xiao D; Lew KL; Hershberger P; Kokkinakis DM; Johnson CS; Trump DL; Singh SV
Carcinogenesis; 2003 Oct; 24(10):1665-70. PubMed ID: 12896904
[TBL] [Abstract][Full Text] [Related]
30. Characterization of a transplantable hormone-responsive human prostatic cancer xenograft TEN12 and its androgen-resistant sublines.
Harper ME; Goddard L; Smith C; Nicholson RI
Prostate; 2004 Jan; 58(1):13-22. PubMed ID: 14673948
[TBL] [Abstract][Full Text] [Related]
31. Relaxin becomes upregulated during prostate cancer progression to androgen independence and is negatively regulated by androgens.
Thompson VC; Morris TG; Cochrane DR; Cavanagh J; Wafa LA; Hamilton T; Wang S; Fazli L; Gleave ME; Nelson CC
Prostate; 2006 Dec; 66(16):1698-709. PubMed ID: 16998820
[TBL] [Abstract][Full Text] [Related]
32. Selenite treatment inhibits LAPC-4 tumor growth and prostate-specific antigen secretion in a xenograft model of human prostate cancer.
Bhattacharyya RS; Husbeck B; Feldman D; Knox SJ
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):935-40. PubMed ID: 18760546
[TBL] [Abstract][Full Text] [Related]
33. Molecular analysis integrating different pathways associated with androgen-independent progression in LuCaP 23.1 xenograft.
Rocchi P; Muracciole X; Fina F; Mulholland DJ; Karsenty G; Palmari J; Ouafik L; Bladou F; Martin PM
Oncogene; 2004 Dec; 23(56):9111-9. PubMed ID: 15489889
[TBL] [Abstract][Full Text] [Related]
34. Comparison of immunohistochemistry for activated caspase-3 and cleaved cytokeratin 18 with the TUNEL method for quantification of apoptosis in histological sections of PC-3 subcutaneous xenografts.
Duan WR; Garner DS; Williams SD; Funckes-Shippy CL; Spath IS; Blomme EA
J Pathol; 2003 Feb; 199(2):221-8. PubMed ID: 12533835
[TBL] [Abstract][Full Text] [Related]
35. The ceramide analog, B13, induces apoptosis in prostate cancer cell lines and inhibits tumor growth in prostate cancer xenografts.
Samsel L; Zaidel G; Drumgoole HM; Jelovac D; Drachenberg C; Rhee JG; Brodie AM; Bielawska A; Smyth MJ
Prostate; 2004 Mar; 58(4):382-93. PubMed ID: 14968439
[TBL] [Abstract][Full Text] [Related]
36. Heat shock protein 27 increases after androgen ablation and plays a cytoprotective role in hormone-refractory prostate cancer.
Rocchi P; So A; Kojima S; Signaevsky M; Beraldi E; Fazli L; Hurtado-Coll A; Yamanaka K; Gleave M
Cancer Res; 2004 Sep; 64(18):6595-602. PubMed ID: 15374973
[TBL] [Abstract][Full Text] [Related]
37. Cell proliferation and apoptosis during prostatic tumor xenograft involution and regrowth after castration.
Bladou F; Vessella RL; Buhler KR; Ellis WJ; True LD; Lange PH
Int J Cancer; 1996 Sep; 67(6):785-90. PubMed ID: 8824549
[TBL] [Abstract][Full Text] [Related]
38. [Construction of autocatalytic caspase-3 driven by amplified human telomerase reverse transcriptase promoter and its enhanced efficacy of inducing apoptosis in human ovarian carcinoma].
Song Y; Shen K; He CX
Zhonghua Fu Chan Ke Za Zhi; 2007 Sep; 42(9):617-22. PubMed ID: 17983518
[TBL] [Abstract][Full Text] [Related]
39. Induction of apoptosis in prostate tumor PC-3 cells and inhibition of xenograft prostate tumor growth by the vanilloid capsaicin.
Sánchez AM; Sánchez MG; Malagarie-Cazenave S; Olea N; Díaz-Laviada I
Apoptosis; 2006 Jan; 11(1):89-99. PubMed ID: 16374544
[TBL] [Abstract][Full Text] [Related]
40. Androgen-dependent expression of the gastrin-releasing peptide receptor in human prostate tumor xenografts.
de Visser M; van Weerden WM; de Ridder CM; Reneman S; Melis M; Krenning EP; de Jong M
J Nucl Med; 2007 Jan; 48(1):88-93. PubMed ID: 17204703
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]